Biomarin Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 19.14 M | $1.14 B | -13.20% | 9.99% |
| VANGUARD GROUP INC | 01/29/2026 | 18.13 M | $1.08 B | -2.45% | 9.46% |
| DODGE & COX | 02/13/2026 | 14.57 M | $866.04 M | -0.78% | 7.60% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/11/2026 | 14.55 M | $864.67 M | -4.46% | 7.59% |
| NORGES BANK | 02/10/2026 | 7.53 M | $447.57 M | 100.00% | 3.93% |
| STATE STREET CORP | 02/13/2026 | 7.52 M | $447.10 M | -14.16% | 3.93% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 6.69 M | $395.20 M | 12.72% | 3.49% |
| VIKING GLOBAL INVESTORS LP | 02/17/2026 | 6.04 M | $358.78 M | -27.46% | 3.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.67 M | $218.39 M | 3.73% | 1.92% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 3.32 M | $197.40 M | 47.95% | 1.73% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 3.04 M | $180.53 M | 15.62% | 1.59% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 3.00 M | $178.29 M | 261.45% | 1.57% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 2.55 M | $151.39 M | 0.38% | 1.33% |
| MORGAN STANLEY | 02/13/2026 | 2.32 M | $137.62 M | 67.74% | 1.21% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 2.30 M | $136.69 M | 9,153.30% | 1.20% |
| UBS GROUP AG | 01/29/2026 | 2.21 M | $131.44 M | 43.60% | 1.15% |
| FMR LLC | 02/17/2026 | 1.84 M | $109.18 M | 367.67% | 0.96% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 1.83 M | $108.66 M | 31.68% | 0.95% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.55 M | $92.00 M | -6.88% | 0.81% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 1.47 M | $87.08 M | 19.25% | 0.76% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 1.44 M | $85.38 M | 452.07% | 0.75% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.42 M | $84.61 M | 1.87% | 0.74% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 1.42 M | $84.34 M | 312.35% | 0.74% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.36 M | $81.10 M | 243.02% | 0.71% |
| DNB ASSET MANAGEMENT AS | 02/05/2026 | 1.36 M | $80.80 M | 6.69% | 0.71% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.32 M | $78.74 M | -30.03% | 0.69% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 1.32 M | $78.45 M | 48.26% | 0.69% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.28 M | $76.43 M | 44.19% | 0.67% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 1.23 M | $73.11 M | -10.36% | 0.64% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 1.17 M | $69.34 M | 30.37% | 0.61% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 1.11 M | $57.71 M | -16.56% | 0.58% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 02/17/2026 | 1.05 M | $62.33 M | 14.86% | 0.55% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.00 M | $59.67 M | 264.79% | 0.52% |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 945.85 K | $56.21 M | 4.39% | 0.49% |
| PACER ADVISORS, INC. | 02/24/2026 | 937.36 K | $55.71 M | 53.63% | 0.49% |
| RIVER ROAD ASSET MANAGEMENT, LLC | 02/24/2026 | 906.37 K | $53.87 M | 100.00% | 0.47% |
| LSV ASSET MANAGEMENT | 02/06/2026 | 882.20 K | $52.43 M | 4.34% | 0.46% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 864.51 K | $51.38 M | -8.96% | 0.45% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 850.78 K | $50.56 M | -12.88% | 0.44% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 849.74 K | $50.50 M | 126.78% | 0.44% |
| SWEDBANK AB | 02/09/2026 | 796.74 K | $47.35 M | 70.63% | 0.42% |
| THRIVENT FINANCIAL FOR LUTHERANS | 02/05/2026 | 794.65 K | $47.23 M | 2.13% | 0.41% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 785.10 K | $46.66 M | 100.00% | 0.41% |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 01/23/2026 | 766.43 K | $45.55 M | -18.07% | 0.40% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 746.26 K | $44.35 M | -1.03% | 0.39% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 731.50 K | $43.47 M | 16.44% | 0.38% |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 01/13/2026 | 713.98 K | $42.43 M | 0.00% | 0.37% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 711.77 K | $42.30 M | -0.17% | 0.37% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 697.13 K | $41.43 M | 100.00% | 0.36% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 687.66 K | $40.87 M | -36.68% | 0.36% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biomarin Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 912 institutional investors and hedge funds held shares of Biomarin Pharmaceutical Inc.. The most heavily invested institutionals were:
PRIMECAP MANAGEMENT CO/CA/: 14.19 M
DIMENSIONAL FUND ADVISORS LP: 3.8 M
Assenagon Asset Management S.A.: 1.92 M
UBS Group AG: 1.5 M
VANGUARD FIDUCIARY TRUST CO: 1.19 M
Pictet Asset Management Holding SA: 1.19 M
98.19% of Biomarin Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 253.67 M shares in the last 24 months. This purchase volume represents approximately $15.44 B in transactions.